Skip to content

Public FDA record

Z-2427-2024: A610 Clinician Programmer (CP) Software Application (app) with the following versions: Version 2.0.x (2.0

Recall record Z-2427-2024 for Medtronic Neuromodulation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2427-2024
Company in FDA record
Medtronic Neuromodulation
FDA classification date
Jul 24, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Patients implanted with a pocket adaptor (Model 64001 and/or 64002) are limited to HEAD ONLY MRI eligibility.

Source facts

Action
Recall notice sent to consignees beginning on 05/14/2024 via mail. Consignees are asked to confirm or revise the MRI eligibility display on the programmer, pass on the notice to all those who need to be aware within your organization and to other organizations on which this action has an impact, and confirm they have read and understand the customer actions within the letter and to return the signed confirmation form back to Medtronic. An UPDATE TO MEDICAL DEVICE CORRECTION RE: A610 Replacement workflow with DBS Pocket Adaptor affecting MRI eligibility display letter dated January 2025 was sent to customers. ***Updated March 2025*** Beginning March 21, 2025, Medtronic began communications that the software and firmware will be made available to customers in the United States and Puerto Rico Customer actions: "Please share this notice with all those who need to be aware of this issue within your organization,or to any organization where the identified clinician tablet(s) have been transferred and maintain acopy of this notice in your records. "Your Medtronic Deep Brain Stimulation (DBS) sales representative will distribute the new tabletand/or assist with installation of the A610 version 5.0 as soon as those are available in your region.If you have any questions, please contact your Medtronic Sales Representative. "Following review of this letter, sign and return the enclosed Confirmation Form via email toneuro.quality@medtronic.com.
Initiated
2024-05-15
Root cause
Under Investigation by firm
Distribution
Worldwide distribution - US Nationwide and the countries of Algeria, Argentina, Australia, Austria, Belgium, Bolivia, Brazil, Canada, Canary Islands, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Iceland, India, Iran, Islamic Republic Of, Ireland, Israel, Italy, Japan, Jordan, Korea, Republic Of, Kuwait, Latvia, Lebanon, Lithuania, Luxembourg, Malaysia, Malta, Mexico, Morocco, Netherlands, New Zealand, Northern Ireland, Norway, Pakistan, Peru, Philippines, Poland, Portugal, Puerto Rico, Reunion, Russian Federation, Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, United Kingdom, Uruguay, Viet Nam.
Recall number
Z-2427-2024
Recall status
Open, Classified
CDRH record ID
208483
FDA classified
2024-07-24
Recall event number
94845

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗